| pubmed-article:3330928 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3330928 | lifeskim:mentions | umls-concept:C0026955 | lld:lifeskim |
| pubmed-article:3330928 | lifeskim:mentions | umls-concept:C1005777 | lld:lifeskim |
| pubmed-article:3330928 | lifeskim:mentions | umls-concept:C0441472 | lld:lifeskim |
| pubmed-article:3330928 | lifeskim:mentions | umls-concept:C0205409 | lld:lifeskim |
| pubmed-article:3330928 | lifeskim:mentions | umls-concept:C0070521 | lld:lifeskim |
| pubmed-article:3330928 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:3330928 | pubmed:dateCreated | 1988-8-8 | lld:pubmed |
| pubmed-article:3330928 | pubmed:abstractText | Phaseolinone was mutagenic to excision-repair-deficient strains of Escherichia coli WP2 and also to Salmonella typhimurium TA 100. The repair test was indicative of covalent binding of the toxin to DNA. The side-chain epoxide and the hydroxy groups of the molecule were found to be essential for mutagenic activity. | lld:pubmed |
| pubmed-article:3330928 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3330928 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3330928 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3330928 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3330928 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3330928 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3330928 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3330928 | pubmed:issn | 0004-9417 | lld:pubmed |
| pubmed-article:3330928 | pubmed:author | pubmed-author:SiddiquiK AKA | lld:pubmed |
| pubmed-article:3330928 | pubmed:author | pubmed-author:Bhattacharyya... | lld:pubmed |
| pubmed-article:3330928 | pubmed:author | pubmed-author:BhattacharyaG... | lld:pubmed |
| pubmed-article:3330928 | pubmed:author | pubmed-author:DharT KTK | lld:pubmed |
| pubmed-article:3330928 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3330928 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:3330928 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3330928 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3330928 | pubmed:pagination | 349-53 | lld:pubmed |
| pubmed-article:3330928 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:3330928 | pubmed:meshHeading | pubmed-meshheading:3330928-... | lld:pubmed |
| pubmed-article:3330928 | pubmed:meshHeading | pubmed-meshheading:3330928-... | lld:pubmed |
| pubmed-article:3330928 | pubmed:meshHeading | pubmed-meshheading:3330928-... | lld:pubmed |
| pubmed-article:3330928 | pubmed:meshHeading | pubmed-meshheading:3330928-... | lld:pubmed |
| pubmed-article:3330928 | pubmed:meshHeading | pubmed-meshheading:3330928-... | lld:pubmed |
| pubmed-article:3330928 | pubmed:meshHeading | pubmed-meshheading:3330928-... | lld:pubmed |
| pubmed-article:3330928 | pubmed:meshHeading | pubmed-meshheading:3330928-... | lld:pubmed |
| pubmed-article:3330928 | pubmed:meshHeading | pubmed-meshheading:3330928-... | lld:pubmed |
| pubmed-article:3330928 | pubmed:meshHeading | pubmed-meshheading:3330928-... | lld:pubmed |
| pubmed-article:3330928 | pubmed:meshHeading | pubmed-meshheading:3330928-... | lld:pubmed |
| pubmed-article:3330928 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3330928 | pubmed:articleTitle | Mutagenic action of phaseolinone, a mycotoxin isolated from Macrophomina phaseolina. | lld:pubmed |
| pubmed-article:3330928 | pubmed:affiliation | Indian Institute of Chemical Biology, Jadavpur, Calcutta. | lld:pubmed |
| pubmed-article:3330928 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3330928 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3330928 | lld:pubmed |
